The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACTIVISION BLIZZARD INC COM 00507V109   1,653 21,600 SH   SOLE   21,600 0 0
AKERO THERAPEUTICS INC COM 00973Y108   179,296 3,271,829 SH   SOLE   3,271,829 0 0
SPDR SER TR S&P BIOTECH 78464A870   140 1,686 SH   SOLE   1,686 0 0
STOKE THERAPEUTICS INC COM 86150R107   133,315 14,443,681 SH   SOLE   14,443,681 0 0